Hanmi Pharm announced on Nov. 30 that it
received the "K-ICT Information Protection Award" for the first time
in the pharmaceutical bio industry.
The K-ICT Information Protection Grand
Prize, which marks its 19th anniversary this year, is awarded by the Ministry
of Science and ICT to companies and individuals who practice raising awareness
of information protection and protecting autonomous information.
As a result of three stages of screening by
the Science and Technology Evaluation Committee, Hanmi Pharm received the honor
for the first time in the pharmaceutical industry as it was highly praised for
its information protection management, excellence in information protection
technology, and ability to respond to infringement.
Hanmi Pharm has established and implemented
a systematic and independent information protection management system in
preparation for the growing threat of cyber terrorism and information leakage
for pharmaceutical bio companies.
In particular, Hanmi Pharm received
excellent reviews in this award for operating an information protection
committee to protect information and establishing its own development system to
protect information on new drugs.
In fact, up until now since two years
before the official activities of the information protection committee began,
no information protection violations, personal information leaks, or security
incidents have occurred.
In addition to this award, Hanmi Pharm
acquired the ISO27001 (International Information Protection Management System)
for the first time in the Korean pharmaceutical industry in 2018.
